Table 2.

Demographics by stroke scale and cluster.

Characteristic	All data	NIHSS cluster							FMA clusters			BI cluster						WMFT clusters
	N = 22a	1, N = 4a	2, N = 3a	3, N = 8a	4, N = 4a	5, N = 2a	6, N = 1a	p -value b	1, N = 18a	2, N = 4a	p -value c	1, N = 2a	2, N = 5a	3, N = 6a	4, N = 3a	5, N = 6a	p -value b	1, N = 16a	2, N = 6a	p -value c
Lesion side
Left	7 (32%)	1 (25%)	1 (33%)	3 (38%)	2 (50%)	0 (0%)	0 (0%)	>0.9	6 (33%)	1 (25%)	>0.9	0 (0%)	3 (60%)	1 (17%)	2 (67%)	1 (17%)	0.3	5 (31%)	2 (33%)	>0.9
Right	15 (68%)	3 (75%)	2 (67%)	5 (62%)	2 (50%)	2 (100%)	1 (100%)		12 (67%)	3 (75%)		2 (100%)	2 (40%)	5 (83%)	1 (33%)	5 (83%)		11 (69%)	4 (67%)
Gender
Female	11 (50%)	3 (75%)	1 (33%)	4 (50%)	2 (50%)	0 (0%)	1 (100%)	0.6	8 (44%)	3 (75%)	0.6	2 (100%)	2 (40%)	2 (33%)	2 (67%)	3 (50%)	0.7	7 (44%)	4 (67%)	0.6
Male	11 (50%)	1 (25%)	2 (67%)	4 (50%)	2 (50%)	2 (100%)	0 (0%)		10 (56%)	1 (25%)		0 (0%)	3 (60%)	4 (67%)	1 (33%)	3 (50%)		9 (56%)	2 (33%)
Patient age	64 (56, 68)	58 (55, 62)	49 (48, 59)	64 (62, 66)	64 (55, 72)	78 (77, 80)	67 (67, 67)	0.2	64 (56, 67)	69 (64, 72)	0.2	57 (55, 59)	66 (65, 68)	69 (52, 74)	64 (61, 65)	60 (56, 66)	0.8	64 (58, 67)	62 (54, 70)	>0.9
Hospitalization (days)	9.50 (9.00, 10.75)	10.00 (9.00, 11.25)	9.00 (8.50, 9.00)	10.00 (8.75, 10.00)	11.50 (10.75, 12.00)	8.50 (8.25, 8.75)	8.00 (8.00, 8.00)	0.073	9.00 (9.00, 10.00)	10.50 (9.50, 11.25)	0.5	11.50 (11.25, 11.75)	9.00 (9.00, 9.00)	9.00 (8.00, 10.75)	12.00 (10.50, 12.00)	9.50 (9.00, 10.00)	0.2	9.00 (8.75, 10.00)	11.50 (10.25, 12.00)	0.045
History of cerebrovascular disease
No	22 (100%)	4 (100%)	3 (100%)	8 (100%)	4 (100%)	2 (100%)	1 (100%)		18 (100%)	4 (100%)		2 (100%)	5 (100%)	6 (100%)	3 (100%)	6 (100%)		16 (100%)	6 (100%)
Hypertension	12 (55%)	2 (50%)	1 (33%)	5 (62%)	3 (75%)	1 (50%)	0 (0%)	0.9	10 (56%)	2 (50%)	>0.9	0 (0%)	4 (80%)	3 (50%)	1 (33%)	4 (67%)	0.4	9 (56%)	3 (50%)	>0.9
Diabetes	9 (41%)	1 (25%)	2 (67%)	4 (50%)	1 (25%)	1 (50%)	0 (0%)	0.9	8 (44%)	1 (25%)	0.6	0 (0%)	4 (80%)	2 (33%)	0 (0%)	3 (50%)	0.2	8 (50%)	1 (17%)	0.3
Coronary Heart Disease	2 (9.1%)	1 (25%)	0 (0%)	1 (12%)	0 (0%)	0 (0%)	0 (0%)	>0.9	2 (11%)	0 (0%)	>0.9	0 (0%)	1 (20%)	0 (0%)	1 (33%)	0 (0%)	0.4	2 (12%)	0 (0%)	>0.9
Hyperlipidemia	9 (41%)	0 (0%)	2 (67%)	5 (62%)	1 (25%)	1 (50%)	0 (0%)	0.3	8 (44%)	1 (25%)	0.6	0 (0%)	4 (80%)	2 (33%)	0 (0%)	3 (50%)	0.2	8 (50%)	1 (17%)	0.3
TMS protocol
High freq	10 (45%)	2 (50%)	0 (0%)	4 (50%)	2 (50%)	1 (50%)	1 (100%)	0.7	7 (39%)	3 (75%)	0.3	0 (0%)	2 (40%)	3 (50%)	1 (33%)	4 (67%)	0.5	7 (44%)	3 (50%)	0.7
iTBS	5 (23%)	2 (50%)	1 (33%)	1 (12%)	1 (25%)	0 (0%)	0 (0%)		4 (22%)	1 (25%)		2 (100%)	0 (0%)	1 (17%)	1 (33%)	1 (17%)		3 (19%)	2 (33%)
Low freq	7 (32%)	0 (0%)	2 (67%)	3 (38%)	1 (25%)	1 (50%)	0 (0%)		7 (39%)	0 (0%)		0 (0%)	3 (60%)	2 (33%)	1 (33%)	1 (17%)		6 (38%)	1 (17%)
TMS side
Contralateral	10 (45%)	2 (50%)	2 (67%)	4 (50%)	1 (25%)	1 (50%)	0 (0%)	>0.9	10 (56%)	0 (0%)	0.1	1 (50%)	3 (60%)	2 (33%)	2 (67%)	2 (33%)	0.9	9 (56%)	1 (17%)	0.2
Ipsilateral	12 (55%)	2 (50%)	1 (33%)	4 (50%)	3 (75%)	1 (50%)	1 (100%)		8 (44%)	4 (100%)		1 (50%)	2 (40%)	4 (67%)	1 (33%)	4 (67%)		7 (44%)	5 (83%)

^an (%); median (IQR)

^bFisher's exact test; Kruskal–Wallis rank-sum test.

^cFisher's exact test; Wilcoxon rank-sum test.